In Vitro Chemosensitivity & Chemoresistance Assays - R5 - Effective February 25, 2021

This Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: L37628
LCD Title: In Vitro Chemosensitivity & Chemoresistance Assays
Effective Date: February 25, 2021
Summary of Changes:

  • Under CMS National Coverage Policy updated description for regulation Title XVIII of Social Security Act, §1862(a)(1)(D) and revised regulation 42 CFR §410.32(d)(3) to read "42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions".
  • Under Summary of Evidence subheading Studies corrected the broken hyperlink in 12th paragraph.
  • Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD. Acronyms were inserted where appropriate throughout the LCD.

Visit the Active LCDs webpage to view the locally hosted Active LCD or access it via the CMS MCD.

            Last Updated Tue, 23 Feb 2021 19:10:55 +0000